SPIRONOLACTONE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 53 adverse event reports in the FDA FAERS database where SPIRONOLACTONE was used for Psoriasis.
Most Reported Side Effects for SPIRONOLACTONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Acute kidney injury | 3,273 | 15.6% | 256 | 2,669 |
| Hyperkalaemia | 2,518 | 12.0% | 154 | 1,871 |
| Hypotension | 1,583 | 7.5% | 131 | 1,081 |
| Dyspnoea | 1,468 | 7.0% | 62 | 1,043 |
| Drug ineffective | 1,379 | 6.6% | 65 | 642 |
| Hyponatraemia | 1,166 | 5.5% | 72 | 975 |
| Dizziness | 991 | 4.7% | 39 | 495 |
| Fatigue | 990 | 4.7% | 29 | 520 |
| Fall | 947 | 4.5% | 76 | 783 |
| Off label use | 899 | 4.3% | 53 | 357 |
| Dehydration | 897 | 4.3% | 74 | 722 |
| Cardiac failure | 781 | 3.7% | 146 | 548 |
| Headache | 723 | 3.4% | 12 | 418 |
| Condition aggravated | 714 | 3.4% | 84 | 461 |
| Drug interaction | 714 | 3.4% | 47 | 521 |
Other Indications for SPIRONOLACTONE
Product used for unknown indication (7,297)
Hypertension (3,316)
Cardiac failure (1,622)
Ascites (387)
Diuretic therapy (375)
Cardiac failure congestive (348)
Acne (306)
Oedema (254)
Cardiac failure chronic (176)
Oedema peripheral (160)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)